Ciclosporin
Ciclosporin is a pharmaceutical drug with 25 clinical trials. Currently 2 active trials ongoing. Historical success rate of 81.0%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
11
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.0%
17 of 21 finished
19.0%
4 ended early
2
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients
CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
Clinical Trials (25)
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients
CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir
Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA
Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy
Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
Ciclosporin to Reduce Reperfusion Injury in Primary PCI
A Study of Baricitinib and Ciclosporin in Healthy Participants
The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets
Ciclosporin to Protect Renal Function In Cardiac Surgery
Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Ciclosporin in the Management of New Erythema Nodosum Leprosum
Pilot Study of Unrelated Cord Blood Transplantation
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25